Table 1.
Cell assay data was obtained at least in triplicate (wells) in each condition. Amino acids were either purchased (50–62, 65, 71, 85), synthesized as previously published (68–70),56 or synthesized according to Scheme 1. All compounds above are single enantiomers of L configuration, unless indicated otherwise.
Compounds were tested at 200 μM for their ability to cause efflux (fmol/min) of [3H]-gabapentin from preloaded HEK-hLAT1 cells. Efflux of [3H]-gabapentin was calculated at 3 min after adding test compound. %Efflux was normalized relative to L-Phe (50), which had an efflux rate of 2.7 ± 0.3 fmol/min, from an average of seven experiments.
Compounds were tested at 200 μM for their ability to inhibit uptake of [3H]-gabapentin into HEIK-hLAT1 cells. Data are presented as % inhibition relative to background signal in the absence of a test compound.
For IC50 determinations, varying concentrations of each compound were added, from 0.1 to 500 μM. IC50 and standard deviation of each compound were calculated by Graphpad Prism version 5.0. %[3H]-gabapentin uptake at each concentration was normalized relative to % inhibition by BCH80,51 at 2 mM, which was set to 100% inhibition.